Cereno Scientific: Science, Patients & Opportunity | Capital Markets Day 2026

Perspektiv från talarna: Vetenskap, patienter och möjligheter

Den här videon ger en inblick i Cereno Scientifics pipeline, strategi och potential inom behandling av sällsynta hjärt- och lungsjukdomar. Inspelad den 5 februari 2026 under kapitalmarknadsdagen.

Visa video >

Mer information:

What makes Cereno Scientific an exciting company to follow?

In this video from Cereno Scientific’s Capital Markets Day 2026, speakers share perspectives on the scientific progress, patient impact, and long-term opportunity behind the company’s mission to pioneer disease-modifying treatments for rare cardiovascular and pulmonary diseases.

The discussion highlights the significant unmet medical need in pulmonary arterial hypertension (PAH), where current therapies primarily manage symptoms without slowing down, halting or reversing disease progression. Through insights from external experts, patient representatives, and members of Cereno’s leadership team, the video explores how innovative approaches targeting underlying disease mechanisms could potentially change treatment outcomes for patients.

Speakers also discuss the experience of the team, the company’s clinical development strategy, and the milestones ahead as Cereno advances its pipeline.